How to present software risk to an investment committee is a question of translation, not just analysis. The diligence team may have found a precise eight figure licensing exposure, but if it lands as a forty page technical report the committee cannot price it, cannot compare it to the other deal risks, and cannot approve against it. Presenting software risk to an investment committee means compressing the work into a single, defensible number, a clear range, and a short set of actions the committee can weigh against the return. The detail belongs in the appendix. The decision needs one page.
This guide sets out how to present software risk to an investment committee so the finding drives a decision rather than a debate. It is the reporting end of the core software due diligence method and draws on quantifying software audit exposure before you sign. For the underlying report structure, pair it with the software due diligence deliverables and DD report.
What an investment committee actually needs to see
An investment committee weighs risk against return across many workstreams in a short meeting. For software it needs four things: the size of the exposure as a range, the likelihood it crystallises, the cost and time to cure it, and the recommended treatment in the deal, whether that is a price adjustment, an escrow, an indemnity, or a post close work plan. Everything else is supporting evidence. The committee does not need the methodology defended line by line; it needs to trust that the number is defensible and to know what happens if it is wrong.
Express the exposure as a range with a confidence level
The single most useful thing the diligence team can do is present a range rather than a false point estimate. A range with a low, base, and high case, each with a stated confidence level and the assumptions behind it, lets the committee see both the expected cost and the tail. A single number invites a false sense of precision and collapses the first time a publisher disagrees. Anchor the credibility of the range with dated proof points. As of June 2026, SAP was reported to have pursued AB InBev for around 600 million dollars and Diageo for around 60 million over disputed and inherited licensing, which shows why the high case is not alarmism. Confirm current figures with primary sources.
Key takeaways
- An investment committee needs the size, the likelihood, the cost to cure, and the recommended treatment, not the full methodology. The detail belongs in the appendix.
- Present the exposure as a range with a confidence level, not a false single figure that collapses the first time a publisher disagrees.
- Translate every finding into a deal action: a price adjustment, an escrow, an indemnity, or a post close work plan the committee can approve.
- Anchor the high case with dated public proof points so the committee sees the tail risk is real, not pessimism.
Turn every finding into a deal action
A finding that does not map to an action wastes the committee time. For each material exposure, recommend the treatment: price it into the offer, hold it in escrow, cover it with a specific indemnity in the sale agreement, or accept it as a post close work plan with an owner and a budget. This is where commercial diligence earns its place, because it does not just report the risk, it tells the committee how to carry it. Keep the legal interpretation with the buyer own counsel and present the commercial recommendation clearly, so the committee can decide how much exposure to push into price and how much into the agreement.
Anticipate the committee questions before the meeting
A strong presentation pre empts the obvious challenges. The committee will ask how confident the team is, what the worst credible case looks like, whether the exposure is one off or recurring, and what the seller knows. Prepare a crisp answer to each, with the supporting evidence one click away in the appendix. The goal is a meeting where the software risk is understood and priced in minutes rather than debated for an hour, because the page already answers the questions a sharp committee member would raise.
Recommendations for buyers
- Build a one page summary with five lines: headline exposure as a range, likelihood, cost to cure, recommended treatment, and confidence.
- Lead with the number and the action, and keep the per publisher calculations and contract citations in a referenced appendix.
- Recommend a specific deal treatment for every material exposure rather than presenting risk without a route to carry it.
- Rehearse the answers to the predictable committee questions, with the evidence one click away, so the decision is made in the meeting.
How to present software risk to an investment committee under time pressure
Committee meetings are short and software is one item among many, so knowing how to present software risk to an investment committee means earning the decision in the first ninety seconds. Open with the base case exposure and the recommended treatment, not the background. State the range and the confidence in one breath, then show the single action you are asking the committee to approve. Only if a member pushes do you open the appendix. This inversion, conclusion first and evidence on demand, is what separates a presentation that secures a decision from one that consumes the meeting and defers it.
Match the language to the room. A committee thinks in money, probability, and time, so translate every technical finding into those terms before it reaches the page. An Oracle core counting gap becomes a base case figure with a likelihood and a cure cost, not a discussion of processor factors. An SAP indirect access exposure becomes a priced range anchored to the public precedents, not a lecture on digital access. The committee should leave able to repeat the number, the range, and the action to anyone who asks, which is the real test of whether the risk was presented well.
Finally, leave the committee with a clear owner and a next step, not an open question. If the recommendation is an escrow, name the figure and the trigger. If it is a post close work plan, name the owner and the budget. A presentation that ends with a decision the committee can record moves the deal forward, while one that ends with a request for more analysis stalls it and invites the exposure to grow unmanaged until the next meeting.
Why an independent buyer side advisor makes the number credible
A committee weighs the source as well as the number. An exposure presented by a party that earns on the spend, or sourced from the seller, carries less weight than one built by an independent, buyer side advisor with no affiliation to any publisher or reseller. The independence is what lets the committee trust the range without re running the analysis. That credibility, paired with a one page summary and a clear recommendation, is what turns months of diligence into a decision the committee can make with confidence.